| For: | Weiss V, Dueber J, Wright JP, Cates J, Revetta F, Parikh AA, Merchant NB, Shi C. Immunohistochemical analysis of the Wnt/β-catenin signaling pathway in pancreatic neuroendocrine neoplasms. World J Gastrointest Oncol 2016; 8(8): 615-622 [PMID: 27574554 DOI: 10.4251/wjgo.v8.i8.615] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i8/615.htm |
| Number | Citing Articles |
| 1 |
Md. Hafiz Uddin, Md. Najeeb Al-Hallak, Philip A. Philip, Herbert Chen, Bassel El-Rayes, Asfar S. Azmi. Aberrant transcription factors in the cancers of the pancreas. Seminars in Cancer Biology 2022; 86 doi: 10.1016/j.semcancer.2022.08.011
|
| 2 |
B. Zhou, X. Zhou, C. Zhan, M. Jin, S. Yan. FAM83A promotes the progression and metastasis of human pancreatic neuroendocrine tumors by inducing the epithelial–mesenchymal transition via the PI3K/AKT and ERK pathways. Journal of Endocrinological Investigation 2022; 46(6) doi: 10.1007/s40618-022-01959-4
|
| 3 |
Lingaku Lee, Tetsuhide Ito, Robert T Jensen. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Review of Anticancer Therapy 2019; 19(12) doi: 10.1080/14737140.2019.1693893
|
| 4 |
Xi-Feng Jin, Gerald Spöttl, Julian Maurer, Svenja Nölting, Christoph Josef Auernhammer. Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects. Cancers 2020; 12(2) doi: 10.3390/cancers12020345
|
| 5 |
Zena Saleh, Matthew C. Moccia, Zachary Ladd, Upasana Joneja, Yahui Li, Francis Spitz, Young Ki Hong, Tao Gao. Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation. International Journal of Molecular Sciences 2024; 25(2) doi: 10.3390/ijms25021331
|
| 6 |
Yina Jiang, Juan Xie, Bo Wang, Yudong Mu, Peijun Liu. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas. Human Pathology 2018; 81 doi: 10.1016/j.humpath.2018.07.005
|
| 7 |
Jian Guan, Yin Lu, Huijuan Zhang, Wenting Huang. APC-rearranged solid pseudopapillary neoplasm–pancreatic neuroendocrine tumor collision tumor: a molecularly resolved case report. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1796302
|
| 8 |
Maja Kebe Radulovic, Jernej Brecelj, Andrej Gruden, Margareta Strojan Flezar. Role of endoscopic ultrasound-guided fine needle aspiration biopsies in diagnosing pancreatic neoplasms in the paediatric population: experience from a tertiary center and review of the literature. Radiology and Oncology 2024; 58(1) doi: 10.2478/raon-2024-0008
|
| 9 |
Helvijs Niedra, Olesja Rogoza, Rihards Saksis, Raitis Peculis, Anzela Halilova, Aija Gerina, Sofija Vilisova, Natalja Senterjakova, Aldis Pukitis, Ignacio Ruz-Caracuel, Julie Earl, Georgina Kolnikova, Peter Dubovan, Miroslav Tomas, Peter Makovicky, Maria Urbanova, Bozena Smolkova, Eythimios Koniaris, Ioanna Aggelioudaki, Agapi Kataki, Vita Rovite, Xianmin Zhu. Transcriptomic profiling of pancreatic neuroendocrine tumors: dysregulation of WNT, MAPK, PI3K, neddylation pathways and potential non-invasive biomarkers. PLOS One 2025; 20(6) doi: 10.1371/journal.pone.0325672
|
| 10 |
Rui He, Wunai Zhang, Shuo Chen, Yang Liu, Wenbin Yang, Junhui Li. Transcriptional Profiling Reveals the Regulatory Role of DNER in Promoting Pancreatic Neuroendocrine Neoplasms. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.587402
|
| 11 |
Chandra Maharjan, Po Ear, Catherine Tran, James Howe, Chandrikha Chandrasekharan, Dawn Quelle. Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets. Cancers 2021; 13(20) doi: 10.3390/cancers13205117
|
| 12 |
Pengchen Chen, Qingshui Wang, Jianwei Xie, Hang Fai Kwok. Signaling networks and the feasibility of computational analysis in gastroenteropancreatic neuroendocrine tumors. Seminars in Cancer Biology 2019; 58 doi: 10.1016/j.semcancer.2019.04.005
|
| 13 |
Kenichi HIRABAYASHI, Tsubasa SAIKA, Nobuaki KATO, Hitoshi ITOH, Naoya NAKAMURA. Current status of pancreatic juice/pancreatic duct brush cytology and endoscopic ultrasound-guided fine needle aspiration cytology/ biopsy. Suizo 2020; 35(4) doi: 10.2958/suizo.35.293
|
| 14 |
Wenchang Guo, Ted Farzaneh, Whayoung Lee, Ali Nael, Xiaodong Li, Vishal S. Chandan. A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm. Pathology - Research and Practice 2021; 223 doi: 10.1016/j.prp.2021.153462
|
| 15 |
Mengfei Fu, Li Yu, Liu Yang, Yang Chen, Xiao Chen, Qinyu Hu, Hui Sun. Gender differences in pancreatic neuroendocrine neoplasms: A retrospective study based on the population of Hubei Province, China. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.885895
|
| 16 |
Peyman Dinarvand, Wei‐Lien Wang, Sinchita Roy‐Chowdhuri. Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations. Cytopathology 2022; 33(2) doi: 10.1111/cyt.13080
|
| 17 |
M. Adelita Vizcaino, Andrew L. Folpe, Henry Huffman, Ripul R. Panchal, G. Petur Nielsen, Benjamin R. Kipp, Rust Turakulov, Kenneth Aldape, Caterina Giannini. Pseudoendocrine sarcoma: clinicopathologic, molecular, and epigenetic features of one case. Virchows Archiv 2023; 483(6) doi: 10.1007/s00428-023-03695-3
|
| 18 |
Krystallenia I Alexandraki, Gregory A Kaltsas, Niki Karavitaki, Ashley B Grossman. The Medical Therapy of Craniopharyngiomas: The Way Ahead. The Journal of Clinical Endocrinology & Metabolism 2019; 104(12) doi: 10.1210/jc.2019-01299
|
| 19 |
Bo Zhou, Jie Xiang, Ming Jin, Xiang Zheng, Guogang Li, Sheng Yan. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08062-6
|